kind of herpes in tongue, palate and throat; skin burn; skin hurt; dry mouth; Oxygen saturation down; swelling of face and eyes; swelling of face and eyes; hives in the chest; scabs on the head; dizziness; blurry vision; pain in the left eye; difficult breathing; loss of smell; vomiting; fatigue; fever 101 F; itchy hands; headache 15 minutes after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), DYSPNOEA (difficult breathing), ANOSMIA (loss of smell), SWELLING FACE (swelling of face and eyes) and EYE SWELLING (swelling of face and eyes) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in June 2020. Concurrent medical conditions included Asthma and Mite allergy. Concomitant products included ESOMEPRAZOLE for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced FATIGUE (fatigue), PYREXIA (fever 101 F), PRURITUS (itchy hands) and HEADACHE (headache 15 minutes after vaccination). On 09-Jan-2021, the patient experienced VOMITING (vomiting), DYSPNOEA (difficult breathing) and ANOSMIA (loss of smell). On 10-Jan-2021, the patient experienced SWELLING FACE (swelling of face and eyes), EYE SWELLING (swelling of face and eyes), URTICARIA (hives in the chest), SCAB (scabs on the head), DIZZINESS (dizziness), VISION BLURRED (blurry vision) and EYE PAIN (pain in the left eye). On 13-Jan-2021, the patient experienced BLISTER (kind of herpes in tongue, palate and throat), SKIN BURNING SENSATION (skin burn), SKIN DISCOMFORT (skin hurt), DRY MOUTH (dry mouth) and OXYGEN SATURATION DECREASED (Oxygen saturation down). The patient was treated with ACETAMINOPHEN for Headache, at a dose of UNK, q6h. At the time of the report, VOMITING (vomiting), DYSPNOEA (difficult breathing), ANOSMIA (loss of smell), SWELLING FACE (swelling of face and eyes), EYE SWELLING (swelling of face and eyes), URTICARIA (hives in the chest), SCAB (scabs on the head), DIZZINESS (dizziness), VISION BLURRED (blurry vision), EYE PAIN (pain in the left eye), BLISTER (kind of herpes in tongue, palate and throat), SKIN BURNING SENSATION (skin burn), SKIN DISCOMFORT (skin hurt), DRY MOUTH (dry mouth), OXYGEN SATURATION DECREASED (Oxygen saturation down), FATIGUE (fatigue), PYREXIA (fever 101 F), PRURITUS (itchy hands) and HEADACHE (headache 15 minutes after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications includes medications for allergy and asthma.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.